Lv7
4874 积分 2020-06-15 加入
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
17天前
已完结
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
1个月前
已完结
Latent human herpesvirus 6 is reactivated in CAR T cells
1个月前
已完结
Forks in the road for CAR T and CAR NK cell cancer therapies
1个月前
已完结
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
1个月前
已完结
可溶性PD-1/PD-L1在肝癌中的研究进展
1个月前
已完结
Portia: A Phase 1b Study Evaluating Safety and Efficacy of Tisagenlecleucel and Pembrolizumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
1个月前
已关闭
Lenvatinib plus EGFR inhibition for liver cancer
2个月前
已完结
皖公网安备34019202002308
